Submitted:
27 January 2023
Posted:
28 January 2023
You are already at the latest version
Abstract
Keywords:
Introduction
Materials and Methods
Campaign procedure
Statistical methods
Ethical aspects
Results
Discussion
Conclusions
Funding
Acknowledgments
Conflicts of Interest
Abbreviations
| ICHD-3: | International Classification of Headache Disorders 3rd edition |
| MOH: | medication-overuse headache |
| OTC: | over-the-counter |
| SNS: | social networking services |
| TTH; | tension-type headache |
| WHO: | World Health Organization |
References
- Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol 2008; 7: 354–361. [CrossRef]
- Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1204–1222.
- No authors listed N. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38: 1–211. [CrossRef]
- Katsuki M, Kawahara J, Matsumori Y, et al. Questionnaire-based survey during COVID-19 vaccination on the prevalence of elderly’s migraine, chronic daily headache, and medication-overuse headache in one Japanese city—Itoigawa Hisui Study. J Clin Med 2022; 11: 4707. [CrossRef]
- Katsuki M, Matsumori Y, Kawahara J, et al. School-based online survey on chronic headache, migraine, and medication-overuse headache prevalence among children and adolescents in Japanese one city -Itoigawa Benizuwaigani Study -. Clin Neurol Neurosurg 2023; in press. [CrossRef]
- Matsumori Y, Ueda K, Komori M, et al. Burden of Migraine in Japan: Results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study. Neurol Ther 2022; 11: 205–222. [CrossRef]
- Katsuki M, Yamagishi C, Matsumori Y, et al. Questionnaire-based survey on the prevalence of medication-overuse headache in Japanese one city-Itoigawa study. Neurol Sci 2022; 43: 3811–3822. [CrossRef]
- Takeshima T, Ishizaki K, Fukuhara Y, et al. Population-based door-to-door survey of migraine in Japan: The Daisen Study. Headache J Head Face Pain 2004; 44: 8–19. [CrossRef]
- Sakai F, Igarashi H. Prevalence of migraine in Japan: A nationwide survey. Cephalalgia 1997; 17: 15–22. [CrossRef]
- Hirata K, Ueda K, Komori M, et al. Comprehensive population-based survey of migraine in Japan: results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) study. Curr Med Res Opin 2021; 37: 1945–1955. [CrossRef]
- Katsuki M, Matsumori Y, Kawahara J, et al. Headache education by leaflets distribution during COVID-19 vaccination and school-based on-demand E-learning -Itoigawa Geopark Headache Awareness Campaign-. Headache 2023; in press. [CrossRef]
- Takeshima T, Wan Q, Zhang Y, et al. Prevalence, burden, and clinical management of migraine in China, Japan, and South Korea: a comprehensive review of the literature. J Headache Pain 2019; 20: 111. [CrossRef]
- Shimizu T, Sakai F, Miyake H, et al. Disability, quality of life, productivity impairment and employer costs of migraine in the workplace. J Headache Pain 2021; 22: 29. [CrossRef]
- Headache Clinical Practice Guideline Development Committee C. [Clinical Practice Guideline for Headache Disorders 2021] (Japanese). Tokyo: Igaku-Shoin, 2021.
- Carlsen LN, Westergaard ML, Bisgaard M, et al. National awareness campaign to prevent medication-overuse headache in Denmark. Cephalalgia 2018; 38: 1316–1325. 1325. [CrossRef]
- Lebedeva ER, Olesen J, Osipova V V, et al. The Yekaterinburg headache initiative: an interventional project, within the Global Campaign against Headache, to reduce the burden of headache in Russia. J Headache Pain 2013; 14: 101. [CrossRef]
- Lai JTF, Dereix JDC, Ganepola RP, et al. Should we educate about the risks of medication overuse headache? J Headache Pain 2014; 15: 10. [CrossRef]
- Nadaoka T, Kanda H, Oiji A, et al. Headache and stress in a group of nurses and government administrators in Japan. Headache 1997; 37: 386–391. [CrossRef]
- Hasegawa M, Kawai H, Nishiwaki K, et al. [The outbreak situation of the physical symptom in the musical instrument exercise of the high school brass band club student] (Japanese). Annu reports Fac Rehabil Shijonawate Gakuen Univ 2010; 6: 13–18.
- Steiner TJ, Birbeck GL, Jensen RH, et al. The Global Campaign turns 18: a brief review of its activities and achievements. J Headache Pain 2022; 23: 49. [CrossRef]
- Kohda T, Nagata H. [Survey on television viewers’ behavior under ‘complex media-environment’] (Japanese). J Inf Media Stud 2012; 11: 15–31.
- Ministry of Internal Affairs and Communications M. [The Evolving Digital Economy and Beyond Society 5.0] (Japanese), https://www.soumu.go.jp/johotsusintokei/whitepaper/ja/r01/html/nd114120.html (2019).
- Kato Y, Poh W, Horvath Z, et al. Impact of COVID-19 pandemic on migraine management in the United States: insights from migraine tracking app users. BMC Neurol 2021; 21: 345. [CrossRef]
- Katsuki M, Tatsumoto M, Kimoto K, et al. Investigating the effects of weather on headache occurrence using a smartphone application and artificial intelligence: a retrospective observational cross-sectional study. Headache 2023; Submitted. [CrossRef]
- Katsuki M. The first case series from Japan of primary headache patients treated by completely online telemedicine. Cureus 2022; 14: e31068. [CrossRef]
- Katsuki M, Narita N, Matsumori Y, et al. Preliminary development of a deep learning-based automated primary headache diagnosis model using Japanese natural language processing of medical questionnaire. Surg Neurol Int 2020; 11: 475. [CrossRef]
| These are the medical facts as stated in the Clinical Practice Guideline for Headache Disorders 2021. Please read and respond to the following question. | ||
|---|---|---|
| Topic number | Statement | Question (choose the answers) |
| Topic 1 | The economic loss caused by headaches, including interference with work, schoolwork, and household chores, has become a social problem. | Yes, I was aware. / No, I was not aware. |
| Topic 2 | The economic loss due to reduced performance in studies and work caused by headaches (presenteeism) is greater than the economic loss due to missed school or work caused by headaches (absenteeism). | Yes, I was aware. / No, I was not aware. |
| Topic 3 | Headache is a symptom; it can be caused by any number of diseases (example: migraine, tension-type headache) | Yes, I was aware. / No, I was not aware. |
| Topic 4 | If you have migraine attacks more than twice a month, if you have strong headaches more than three days a month, or if you take painkillers more than 10 days a month, you should consult doctors. | Yes, I was aware. / No, I was not aware. |
| Topic 5 | There are two important treatments for headaches: (1) acute and (2) prophylactic medications. | Yes, I was aware. / No, I was not aware. |
| Topic 6 | There is a “medication-overuse headache,” in which the headache returns and worsens by taking painkillers for more than 10 days a month. | Yes, I was aware. / No, I was not aware. |
| These are the medical facts as stated in the Clinical Practice Guideline for Headache Disorders 2021. Please read and respond to the following question. | |||||
|---|---|---|---|---|---|
| Users | SNS for nurses | SNS for professional musicians | |||
| Topic number | Statement | Ratio of “I was aware” before e-learning through SNS |
Post 1 month | Ratio of “I was aware” before e-learning through SNS |
Post 1 month |
| Topic 1 | The economic loss caused by headaches, including interference with work, schoolwork, and household chores, has become a social problem. | 27.9% | 93.6% | 18.2% | 84.8% |
| Topic 2 | The economic loss due to reduced performance in studies and work caused by headaches (presenteeism) is greater than the economic loss due to missed school or work caused by headaches (absenteeism). | 22.0% | 94.8% | 15.2% | 88.9% |
| Topic 3 | Headache is a treatable disease. | 30.3% | 98.7% | 21.2% | 84.8% |
| Topic 4 | If you have migraine attacks more than twice a month, if you have strong headaches more than three days a month, or if you take painkillers more than 10 days a month, you should consult doctors. | 41.0% | 97.1% | 47.0% | 80.4% |
| Topic 5 | There are two important treatments for headaches: (1) acute and (2) prophylactic medications. | 40.1% | 95.8% | 21.2% | 91.8% |
| Topic 6 | There is a "medication-overuse headache," in which the headache returns and worsens by taking painkillers for more than 10 days a month. | 36.8% | 92.2% | 39.4% | 90.9% |
| Reasons | Response rate by users in SNS for nurses (n=1191) | Response rate users in SNS for wind instrumental musicians (n=134) |
|---|---|---|
| Because I don't think headaches are sick enough to go to the hospital. | 38.37% | 77.3% |
| Because taking time off from work or school to see a doctor would cause inconvenience to others. | 68.84% | 45.5% |
| Because I cannot take time to visit a hospital during the daytime on weekdays. | 62.30% | 48.5% |
| Because my headache will go away if I just persevere. | 24.43% | 50.0% |
| Because people around me tell me to be patient. | 8.14% | 12.1% |
| Because doctors and co-medical staffs will not be kind to me even if I go to the hospital. | 17.29% | 15.2% |
| Because over-the-counter medicines are sufficient. | 41.22% | 62.1% |
| Because I do not know that there are prophylactic medicines to prevent headaches. | 25.77% | 40.9% |
| Because I feel that my headache does not interfere with my daily life. | 17.71% | 19.7% |
| Strategic objective | Purpose | Action | |
|---|---|---|---|
| 1 | Knowledge for awareness | Establish what it is that requires change | Adduce and collate evidence of the scope and scale of the global burden of headache |
| 2 | Awareness for action | Agitate to create desire for change | Promote awareness, among politicians, health-care providers, employers, schools and the general public, of headache disorders as remediable causes of public ill health and disability, and high financial cost |
| 3 | Action for change | Propose and justify the change to be instigated | Develop evidence-based, adaptable recommendations for intervention, justified by cost-effectiveness analysis |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
